Researchclopedia

Research Researchers Institutions Topics Submit About

Command Palette

Search for a command to run...

Researchclopedia

Research Researchers Institutions About

© 2026 Researchclopedia. Powered by OpenAlex under CC0 license.

Marker Gene Technologies (United States) | Researchclopedia

Back to institutions

Marker Gene Technologies (United States)

Eugene, Oregoncompany

84

Works

4,459

Citations

36

h-index

Top Research Topics

Monoclonal and Polyclonal Antibodies Research Click Chemistry and Applications Cell Image Analysis Techniques

Top Researchers

Rolf Müller University of Bremen

1,185 works51,469 citationsh-index: 94

Recent Research

Advanced machine learning analysis of bioconvection in nanofluid with oxytactic microorganisms in a porous wavy enclosure under inclined periodic magnetic effects

Tarikul Islam,Sílvio Gama,et al.

20251 citations

Advanced Biosensing Techniques and Applications

T-cell and B-cell Immunology

Lysosomal Storage Disorders Research

Protein purification and stability

Advanced biosensing and bioanalysis techniques

Immunotherapy and Immune Responses

RNA Research and Splicing

Cell Adhesion Molecules Research

Single-cell and spatial transcriptomics

Mark D. Eisner University of British Columbia

278 works19,753 citationsh-index: 72

David S. Shames Center for Global Development

311 works19,357 citationsh-index: 65

Yu‐Zhong Zhang Anhui Agricultural University

685 works14,329 citationsh-index: 62

Lukas C. Amler PCR Oncology

295 works13,846 citationsh-index: 53

David Lo University of California, Riverside

181 works11,661 citationsh-index: 54

Combination of Hydroxypropyl-Beta-Cyclodextrin and Trehalose for Improved Stability of Spray-Dried Monoclonal Antibodies

Yu Tong Tam,Aadithya Kannan,et al.

20254 citations

Diffusion tensor MRI is sensitive to fibrotic injury in a mouse model of oxalate-induced chronic kidney disease

Rohan S. Virgincar,Aaron K. Wong,et al.

20243 citations

Abstract PO2-19-09: INAVO122: a Phase III study of maintenance inavolisib or placebo + pertuzumab + trastuzumab following induction with pertuzumab + trastuzumab + a taxane in patients with PIK3CA-mutated, HER2-positive advanced breast cancer

Sandra M. Swain,Carlos H. Barrios,et al.

20241 citations

A Stop-gain in FUT2 Associates With Several COPD Related Phenotypes and Clinical Outcomes

David F. Choy,Evgeniya V. Nazarova,et al.

20241 citations

Analytical evaluation of circulating tumor DNA sequencing assays

Wenjin Li,Xiayu Huang,et al.

202419 citations